Weekly Investment Analysts’ Ratings Changes for Veeva Systems (VEEV)

A number of firms have modified their ratings and price targets on shares of Veeva Systems (NYSE: VEEV) recently:

• 12/22/2025 – Veeva Systems had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – Veeva Systems had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/12/2025 – Veeva Systems had its “sector weight” rating reaffirmed by analysts at KeyCorp.
• 12/8/2025 – Veeva Systems had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/6/2025 – Veeva Systems was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 12/1/2025 – Veeva Systems had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/28/2025 – Veeva Systems was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 11/25/2025 – Veeva Systems had its “buy” rating reaffirmed by analysts at Canaccord Genuity Group Inc..
• 11/25/2025 – Veeva Systems had its price target lowered by analysts at Wells Fargo & Company from $341.00 to $333.00. They now have an “overweight” rating on the stock.
• 11/24/2025 – Veeva Systems was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating.
• 11/24/2025 – Veeva Systems had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $330.00 price target on the stock.
• 11/24/2025 – Veeva Systems had its price target lowered by analysts at Citigroup Inc. from $349.00 to $319.00. They now have a “buy” rating on the stock.
• 11/21/2025 – Veeva Systems had its price target lowered by analysts at Canaccord Genuity Group Inc. from $300.00 to $280.00. They now have a “hold” rating on the stock.
• 11/21/2025 – Veeva Systems had its price target lowered by analysts at Barclays PLC from $325.00 to $305.00. They now have an “overweight” rating on the stock.
• 11/21/2025 – Veeva Systems had its price target lowered by analysts at UBS Group AG from $310.00 to $280.00. They now have a “neutral” rating on the stock.
• 11/21/2025 – Veeva Systems had its price target raised by analysts at Robert W. Baird from $314.00 to $319.00. They now have an “outperform” rating on the stock.
• 11/21/2025 – Veeva Systems had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $340.00 price target on the stock.
• 11/21/2025 – Veeva Systems had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $355.00 price target on the stock.
• 11/13/2025 – Veeva Systems is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $300.00 price target on the stock.
• 11/8/2025 – Veeva Systems was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.

Insider Transactions at Veeva Systems

In other news, insider Thomas D. Schwenger sold 3,350 shares of Veeva Systems stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the transaction, the insider directly owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. The trade was a 12.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the transaction, the insider directly owned 25,325 shares in the company, valued at $7,765,151.50. This represents a 19.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 24,665 shares of company stock worth $7,438,000. 10.30% of the stock is currently owned by insiders.

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.